Recticare Advanced Cream
NDC Package 0496-0978-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Recticare Advanced (lidocaine and mineral oil and phenylephrine hcl and white petrolatum) cream is when practical, cleanse the affected area with mild soap and warm water and rinse thoroughly. This formulation utilizes a cream delivery system. Marketed by Ferndale Laboratories, Inc., this product is identified by NDC 0496-0978 and is authorized under FDA application M015.

Identification & Billing

NDC Package Code
0496-0978-30
Package Description
30 g in 1 TUBE
Product Code
0496-0978
11-Digit Billing Format
00496097830
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
Units Per Package
30 GM
RxNorm Crosswalk
  • RxCUI: 1745450 - lidocaine 5 % / mineral oil 17 % / petrolatum 39 % / phenylephrine HCl 0.25 % Topical Cream
  • RxCUI: 1745450 - lidocaine 50 MG/ML / mineral oil 170 MG/ML / petrolatum 390 MG/ML / phenylephrine hydrochloride 2.5 MG/ML Topical Cream
  • RxCUI: 1745450 - lidocaine 5 % / mineral oil 17 % / petrolatum 39 % / phenylephrine hydrochloride 0.25 % Topical Cream
  • RxCUI: 1745455 - RectiCare Advance Cream 5 % / 17 % / 37 % / 0.25 % Topical Cream
  • RxCUI: 1745455 - lidocaine 50 MG/ML / mineral oil 170 MG/ML / petrolatum 390 MG/ML / phenylephrine hydrochloride 2.5 MG/ML Topical Cream [RectiCare Advance Cream]

Clinical Specifications

Proprietary Name
Recticare Advanced
Non-Proprietary Name
Lidocaine And Mineral Oil And Phenylephrine Hcl And White Petrolatum
Substance Name
Lidocaine; Mineral Oil; Petrolatum; Phenylephrine Hydrochloride
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
When practical, cleanse the affected area with mild soap and warm water and rinse thoroughly. Gently dry by patting or blotting with toilet tissue or soft cloth before applying.adults and children 12 years and older: apply externally to the affected area up to 4 times dailychildren under 12 years of age: consult a doctorTo use finger cots: Roll one finger cot over finger. Gently squeeze cream onto finger cot. Smooth a layer of the cream over affected area.

Regulatory & Marketing

Labeler Name
Ferndale Laboratories, Inc.
Product Type
Human Otc Drug
FDA Application #
M015
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
04-01-2016
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0496-0978). Click a package code to view its specific billing and regulatory data.

0496-0978-15
15 g in 1 TUBE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0496-0978-30 identifies a specific commercial package of 30 g in 1 tube of Recticare Advanced, a human over the counter drug labeled by Ferndale Laboratories, Inc.. This product is billed per "GM" gram and contains an estimated amount of 30 billable units per package. This cream is formulated for topical use and contains lidocaine; mineral oil; petrolatum; phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ferndale Laboratories, Inc. on April 01, 2016. The current certification is valid through December 31, 2026.

How is this Ferndale Laboratories, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00496097830. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0496-0978-30
11-Digit CMS (5-4-2)
00496-0978-30

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.